Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Fuller

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 29, 2019
Simplifying the Diagnosis of Primary AldosteronismJun Yang, Peter J Fuller
Hormones & Cancer|May 16, 2013
Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell linesStacey Jamieson, Peter J Fuller
Current Opinion in Oncology|December 25, 2008
Management of granulosa cell tumour of the ovaryStacey Jamieson, Peter J Fuller
Endocrine Reviews|January 14, 2012
Molecular pathogenesis of granulosa cell tumors of the ovaryStacey Jamieson, Peter J Fuller
Molecular and Cellular Endocrinology|March 20, 2003
Interdomain interactions in the mineralocorticoid receptorFraser M Rogerson, Peter J Fuller
Hypertension (Dallas, Tex. : 1979)|November 16, 2005
Mechanisms of mineralocorticoid actionPeter J Fuller, Morag J Young
The Journal of Endocrinology|December 19, 2009
The importance of ERbeta signalling in the ovaryAnn E Drummond, Peter J Fuller
Molecular and Cellular Endocrinology|August 16, 2011
Activin and inhibin, estrogens and NFκB, play roles in ovarian tumourigenesis is there crosstalk?Ann E Drummond, Peter J Fuller
The New England Journal of Medicine|March 17, 2021
Finerenone and Chronic Kidney Disease Outcomes in Type 2 DiabetesMorag J Young, Peter J Fuller
Hypertension (Dallas, Tex. : 1979)|January 5, 2011
Mineralocorticoid and epidermal growth factor receptors: partners in vivoAmanda J Rickard, Peter J Fuller
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Endocrinology and Metabolism|November 29, 2019
Simplifying the Diagnosis of Primary AldosteronismJun Yang, Peter J Fuller
Hormones & Cancer|May 16, 2013
Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell linesStacey Jamieson, Peter J Fuller
Current Opinion in Oncology|December 25, 2008
Management of granulosa cell tumour of the ovaryStacey Jamieson, Peter J Fuller
Endocrine Reviews|January 14, 2012
Molecular pathogenesis of granulosa cell tumors of the ovaryStacey Jamieson, Peter J Fuller
Molecular and Cellular Endocrinology|March 20, 2003
Interdomain interactions in the mineralocorticoid receptorFraser M Rogerson, Peter J Fuller
Hypertension (Dallas, Tex. : 1979)|November 16, 2005
Mechanisms of mineralocorticoid actionPeter J Fuller, Morag J Young
The Journal of Endocrinology|December 19, 2009
The importance of ERbeta signalling in the ovaryAnn E Drummond, Peter J Fuller
Molecular and Cellular Endocrinology|August 16, 2011
Activin and inhibin, estrogens and NFκB, play roles in ovarian tumourigenesis is there crosstalk?Ann E Drummond, Peter J Fuller
The New England Journal of Medicine|March 17, 2021
Finerenone and Chronic Kidney Disease Outcomes in Type 2 DiabetesMorag J Young, Peter J Fuller
Hypertension (Dallas, Tex. : 1979)|January 5, 2011
Mineralocorticoid and epidermal growth factor receptors: partners in vivoAmanda J Rickard, Peter J Fuller
Pageof 21